xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression

por Ji, Xiangming, Qian, Jun, Rahman, S. M. Jamshedur, Siska, Peter J., Zou, Yong, Harris, Bradford K., Hoeksema, Megan D., Trenary, Irina A., Heidi, Chen, Eisenberg, Rosana, Rathmell, Jeffrey C., Young, Jamey D., Massion, Pierre P.
Publicado 2018

Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer

por Udyavar, Akshata R, Hoeksema, Megan D, Clark, Jonathan E, Zou, Yong, Tang, Zuojian, Li, Zhiguo, Li, Ming, Chen, Heidi, Statnikov, Alexander, Shyr, Yu, Liebler, Daniel C, Field, John, Eisenberg, Rosana, Estrada, Lourdes, Massion, Pierre P, Quaranta, Vito
Publicado 2013